Vaccinations, Variable Risk Lead Payers to End COVID Waivers
Health insurers have begun to phase out the COVID-19 treatment cost-sharing waivers that they have had in place for most of the pandemic. As vaccines have become broadly available in the U.S., insurers are starting to see the novel coronavirus as a “normal” disease — and plan sponsors like Delta Air Lines Inc. are beginning to see health benefits as another means to steer employees toward vaccination.
During most of 2020 and the first half of this year, most carriers took on the full cost of COVID-19 treatment for their fully insured members, waiving copays and other cost sharing. Many self-funded employer plan sponsors did the same. However, both types of health plans have begun to make COVID-19 care a normal health benefit with standard hospitalization and outpatient cost sharing applied.
Meet Our Reporters
-
Jill Drachenberg Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jill Drachenberg's Profile -
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
